NEUROENDOCRINE CARCINOMAS

Clinical trials for NEUROENDOCRINE CARCINOMAS explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CARCINOMAS trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug trial targets Tough-to-Treat rare cancers

Disease control Terminated

This study is testing an experimental drug called XmAb20717 in adults with advanced rare cancers that have few treatment options. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. The trial is currently suspended and is not enrolling …

Matched conditions: NEUROENDOCRINE CARCINOMAS

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

NEUROENDOCRINE CARCINOMAS

Get alerted when new NEUROENDOCRINE CARCINOMAS trials appear

New drug trial targets Tough-to-Treat rare cancers